Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of S-1 with concurrent radiotherapy for locally advanced rectal cancer
ChiCTR-TRC-12002240Phase 2Completed
- Sponsor
- Changhai Hospital
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tegafur in rectal cancer (2 arms), sponsored by Changhai Hospital. Primary endpoints: R0 resection rate and Sphincter-preservation rate. Started May 2012; status: completed.
02
Drugs
tegafur
03
Conditions
rectal cancer
Beyond the preview
Go deeper on ChiCTR-TRC-12002240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002240.